Hemodilution - A blood conservation measure

Normovolemic, hypervolemic or none? - When and how?

G. Singbartl, K. Singbartl, W. Schleinzer

Research output: Contribution to journalArticle

Abstract

Background: Reports in the literature claim acute hypervolemic hemodilution (HHD) a simple alternative to acute normovolemic hemodilution (ANH). However, this is to be answered definitely, only, by mathematical modeling (MM) of ANH versus HHD. Methods: MM of HHD and ANH is based on an exponential decline of the hematocrit (hct) during isovolemically replaced blood loss (BL) (1). The model analyzes a 'standard patient' (70 kg of body weight (b.w.), presumed blood volume 70 ml/kg b.w., initial hct 45% and minimal hct 18%) with an initial preload (iPL) of 200 ml prior to ANH (4 units exchanged, each 500 ml) as well as for 'no ANH' and maintaining hctmin during ongoing BL; and of 1000 ml iPL for HHD and maintaining hypervolemia during BL. Results: Concerning maximal allowable BL (MABL) it is greatest with ANH (6443 ml) and close for HHD (4310 ml) and 'no ANH' (4469 ml). Considering final hct resulting after BL of 2000 ml and with normovolemia reestablished hct-values are close for HHD (32.1%) and for ANH (35.1%); however, ANH is associated either with wasting of ANH-blood (up to 2000 ml at maximum) if ANH-blood is not retransfused or with severe hypervolemia (up to 2000 ml) if ANH-blood is retransfused. Conclusion: For assumed BL of <3 ltr (i.e. approx. 50% of PBV) HHD is a simple / reasonable alternative ' supplement to ANH, while the latter is effectively administered if assumed BL is >3 Itr and low hct-values are tolerated.

Original languageEnglish (US)
Pages (from-to)317
Number of pages1
JournalInfusionstherapie und Transfusionsmedizin
Volume24
Issue number4
StatePublished - 1997

Fingerprint

Hemodilution
hematocrit
blood
Hematocrit
mathematical models
body weight
blood volume
Body Weight

All Science Journal Classification (ASJC) codes

  • Food Science

Cite this

@article{391614a14b694a68ad232fecb1b1c05c,
title = "Hemodilution - A blood conservation measure: Normovolemic, hypervolemic or none? - When and how?",
abstract = "Background: Reports in the literature claim acute hypervolemic hemodilution (HHD) a simple alternative to acute normovolemic hemodilution (ANH). However, this is to be answered definitely, only, by mathematical modeling (MM) of ANH versus HHD. Methods: MM of HHD and ANH is based on an exponential decline of the hematocrit (hct) during isovolemically replaced blood loss (BL) (1). The model analyzes a 'standard patient' (70 kg of body weight (b.w.), presumed blood volume 70 ml/kg b.w., initial hct 45{\%} and minimal hct 18{\%}) with an initial preload (iPL) of 200 ml prior to ANH (4 units exchanged, each 500 ml) as well as for 'no ANH' and maintaining hctmin during ongoing BL; and of 1000 ml iPL for HHD and maintaining hypervolemia during BL. Results: Concerning maximal allowable BL (MABL) it is greatest with ANH (6443 ml) and close for HHD (4310 ml) and 'no ANH' (4469 ml). Considering final hct resulting after BL of 2000 ml and with normovolemia reestablished hct-values are close for HHD (32.1{\%}) and for ANH (35.1{\%}); however, ANH is associated either with wasting of ANH-blood (up to 2000 ml at maximum) if ANH-blood is not retransfused or with severe hypervolemia (up to 2000 ml) if ANH-blood is retransfused. Conclusion: For assumed BL of <3 ltr (i.e. approx. 50{\%} of PBV) HHD is a simple / reasonable alternative ' supplement to ANH, while the latter is effectively administered if assumed BL is >3 Itr and low hct-values are tolerated.",
author = "G. Singbartl and K. Singbartl and W. Schleinzer",
year = "1997",
language = "English (US)",
volume = "24",
pages = "317",
journal = "Transfusion Medicine and Hemotherapy",
issn = "1660-3796",
publisher = "S. Karger AG",
number = "4",

}

Hemodilution - A blood conservation measure : Normovolemic, hypervolemic or none? - When and how? / Singbartl, G.; Singbartl, K.; Schleinzer, W.

In: Infusionstherapie und Transfusionsmedizin, Vol. 24, No. 4, 1997, p. 317.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Hemodilution - A blood conservation measure

T2 - Normovolemic, hypervolemic or none? - When and how?

AU - Singbartl, G.

AU - Singbartl, K.

AU - Schleinzer, W.

PY - 1997

Y1 - 1997

N2 - Background: Reports in the literature claim acute hypervolemic hemodilution (HHD) a simple alternative to acute normovolemic hemodilution (ANH). However, this is to be answered definitely, only, by mathematical modeling (MM) of ANH versus HHD. Methods: MM of HHD and ANH is based on an exponential decline of the hematocrit (hct) during isovolemically replaced blood loss (BL) (1). The model analyzes a 'standard patient' (70 kg of body weight (b.w.), presumed blood volume 70 ml/kg b.w., initial hct 45% and minimal hct 18%) with an initial preload (iPL) of 200 ml prior to ANH (4 units exchanged, each 500 ml) as well as for 'no ANH' and maintaining hctmin during ongoing BL; and of 1000 ml iPL for HHD and maintaining hypervolemia during BL. Results: Concerning maximal allowable BL (MABL) it is greatest with ANH (6443 ml) and close for HHD (4310 ml) and 'no ANH' (4469 ml). Considering final hct resulting after BL of 2000 ml and with normovolemia reestablished hct-values are close for HHD (32.1%) and for ANH (35.1%); however, ANH is associated either with wasting of ANH-blood (up to 2000 ml at maximum) if ANH-blood is not retransfused or with severe hypervolemia (up to 2000 ml) if ANH-blood is retransfused. Conclusion: For assumed BL of <3 ltr (i.e. approx. 50% of PBV) HHD is a simple / reasonable alternative ' supplement to ANH, while the latter is effectively administered if assumed BL is >3 Itr and low hct-values are tolerated.

AB - Background: Reports in the literature claim acute hypervolemic hemodilution (HHD) a simple alternative to acute normovolemic hemodilution (ANH). However, this is to be answered definitely, only, by mathematical modeling (MM) of ANH versus HHD. Methods: MM of HHD and ANH is based on an exponential decline of the hematocrit (hct) during isovolemically replaced blood loss (BL) (1). The model analyzes a 'standard patient' (70 kg of body weight (b.w.), presumed blood volume 70 ml/kg b.w., initial hct 45% and minimal hct 18%) with an initial preload (iPL) of 200 ml prior to ANH (4 units exchanged, each 500 ml) as well as for 'no ANH' and maintaining hctmin during ongoing BL; and of 1000 ml iPL for HHD and maintaining hypervolemia during BL. Results: Concerning maximal allowable BL (MABL) it is greatest with ANH (6443 ml) and close for HHD (4310 ml) and 'no ANH' (4469 ml). Considering final hct resulting after BL of 2000 ml and with normovolemia reestablished hct-values are close for HHD (32.1%) and for ANH (35.1%); however, ANH is associated either with wasting of ANH-blood (up to 2000 ml at maximum) if ANH-blood is not retransfused or with severe hypervolemia (up to 2000 ml) if ANH-blood is retransfused. Conclusion: For assumed BL of <3 ltr (i.e. approx. 50% of PBV) HHD is a simple / reasonable alternative ' supplement to ANH, while the latter is effectively administered if assumed BL is >3 Itr and low hct-values are tolerated.

UR - http://www.scopus.com/inward/record.url?scp=33751239795&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33751239795&partnerID=8YFLogxK

M3 - Article

VL - 24

SP - 317

JO - Transfusion Medicine and Hemotherapy

JF - Transfusion Medicine and Hemotherapy

SN - 1660-3796

IS - 4

ER -